Skip to content

Research and application of medical nutrition intervention on weight loss and gut microbiota impact in overweight/obese patients

Research and application of Study on the Effects of CRD/HPD Medical Nutrition Intervention on Gut Microbiota and Metabolic Indicators in Overweight/Obese Patients

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400091215
Enrollment
Unknown
Registered
2024-10-23
Start date
2023-08-22
Completion date
Unknown
Last updated
2024-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

overweight/obese

Interventions

caloric restriction diet:caloric restriction diet
high protein diet:high protein diet limited energy
caloric restriction diet+probiotic:caloric restriction diet+probiotic
high protein diet+probiotic:high protein diet limited energy +probiotic

Sponsors

Ningxia Hui Autonomous Region People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1: Age at 18-65 years (including 18 years and 65 years old) 2: BMI 24.0-40.0kg/m^2 3: spiritual and cognitive normal, can complete basic communication and communication, can cooperate with research 4: willingness to be willing Sign the project "Inspector Consent" 5: Living in the local area for at least one year.

Exclusion criteria

Exclusion criteria: 1: There are serious diseases such as heart, liver and kidney, or organs, systems and other diseases, or are currently undergoing severe cardiovascular, immunity, breathing, hepatobiliary, kidney and urology, nerves, muscle skeletal, mental, infection and malignant diseases 2: There are gastrointestinal diseases (such as constipation, diarrhea, abdominal pain, intestinal excitement syndrome, and inflammatory bowel disease) 3: Drugs (inhibitors and appetite inhibitors) and probiotic products that affect weight in the past month 4: Recently (over the past 2 months) or continuous use of antibiotics 5: pregnancy and lactation women 6: plan to participate in other clinical trials 7: investigators who believe it is inappropriate for other reasons

Design outcomes

Primary

MeasureTime frame
weight;Waist circumference;Gut microbiota High-throughput sequencing;Body Composition Indicators;

Secondary

MeasureTime frame
Blood lipid indicators;Liver and kidney function;eating habits;Psychological survey;

Countries

China

Contacts

Public ContactZhao Qian

Ningxia Hui Autonomous Region People's Hospital

18995160125@163.com+86 189 9516 0125

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026